Musculoskeletal system | |||||
---|---|---|---|---|---|
Musculoskeletal system / Pain and inflammation in musculoskeletal disorders | |||||
aceclofenac | NON-FORMULARY | ||||
aspirin | NON-FORMULARY | ||||
Gastro-resistant tablet | |||||
Aspirin (Non-proprietary) | NON-FORMULARY | ||||
Nu-Seals (Alliance Pharmaceuticals Ltd) | NON-FORMULARY | ||||
Suppository | |||||
Aspirin (Non-proprietary) | NON-FORMULARY | ||||
celecoxib | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
dexketoprofen | NON-FORMULARY | ||||
diclofenac potassium | NON-FORMULARY | ||||
diclofenac sodium | FORMULARY PRODUCT | ||||
Modified-release tablet | |||||
Dicloflex 75mg SR (Dexcel-Pharma Ltd) | NON-FORMULARY | ||||
Dicloflex Retard (Dexcel-Pharma Ltd) | NON-FORMULARY | ||||
Enstar XL (Ennogen Pharma Ltd) | NON-FORMULARY | ||||
Solution for injection | |||||
Akis (Flynn Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Voltarol (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
etodolac | NON-FORMULARY | ||||
Modified-release tablet | |||||
Etolyn (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Etopan XL (Sun Pharmaceutical Industries Europe B.V.) | NON-FORMULARY | ||||
Lodine SR (Almirall Ltd) | NON-FORMULARY | ||||
etoricoxib | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
flurbiprofen | NON-FORMULARY | ||||
ibuprofen | FORMULARY PRODUCT | ||||
Orodispersible tablet | |||||
Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) | NON-FORMULARY | ||||
Modified-release tablet | |||||
Brufen Retard (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Modified-release capsule | |||||
Ibuprofen (Non-proprietary) | NON-FORMULARY | ||||
Effervescent granules | |||||
Brufen (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Oral suspension | |||||
Ibuprofen (Non-proprietary) | FORMULARY PRODUCT | ||||
Brufen (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | NON-FORMULARY | ||||
indometacin | NON-FORMULARY | ||||
ketoprofen | NON-FORMULARY | ||||
Modified-release capsule | |||||
Oruvail (Sanofi) | NON-FORMULARY | ||||
mefenamic acid | FORMULARY PRODUCT | ||||
meloxicam | FORMULARY PRODUCT | ||||
nabumetone | NON-FORMULARY | ||||
naproxen | FORMULARY PRODUCT | ||||
Gastro-resistant tablet | |||||
Naproxen (Non-proprietary) | NON-FORMULARY | ||||
Naprosyn EC (Atnahs Pharma UK Ltd) | NON-FORMULARY | ||||
Oral suspension | |||||
Naproxen (Non-proprietary) | NON-FORMULARY | ||||
piroxicam | NON-FORMULARY | ||||
Orodispersible tablet | |||||
Feldene Melt (Pfizer Ltd) | NON-FORMULARY | ||||
sulindac | NON-FORMULARY | ||||
tenoxicam | NON-FORMULARY | ||||
tiaprofenic acid | NON-FORMULARY | ||||
Musculoskeletal system / Local inflammation of joints and soft tissue | |||||
dexamethasone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA229 NICE TA824 NICE TA460 |
|||
Oral solution | |||||
Dexamethasone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Solution for injection | |||||
Dexamethasone (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Palliative Care Injectables
According to the East London Health and Care Partnership HOSPITAL ONLY PRESCRIBING LIST this is UNSUITABLE for prescribing in Primary Care unless for Palliative care indication.
|
|||||
hydrocortisone | |||||
Solution for injection | |||||
Hydrocortisone (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
methylprednisolone | NON-FORMULARY | ||||
Powder and solvent for solution for injection | |||||
Solu-Medrone (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Suspension for injection | |||||
Depo-Medrone (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
prednisolone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Gastro-resistant tablet | |||||
Prednisolone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Dilacort (Crescent Pharma Ltd) | NON-FORMULARY | ||||
Oral solution | |||||
Prednisolone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Suppository | |||||
Prednisolone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
triamcinolone acetonide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Suspension for injection | |||||
Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) | NON-FORMULARY | ||||
Musculoskeletal system / Soft tissue disorders | |||||
hyaluronidase | HOSPITAL ONLY PRESCRIBING | ||||
Powder for solution for injection | |||||
Hyaluronidase (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Musculoskeletal system / Hyperuricaemia and gout | |||||
allopurinol | FORMULARY PRODUCT | ||||
canakinumab | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Ilaris (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
colchicine | FORMULARY PRODUCT | ||||
Cochicine for Pericarditis (unlicensed)
Colchicine holds the following formulary status for use in pericarditis: Amber- Specilaist Initiated with continiation in primary care with no shared care.
A clearly defined end date should be specified in the hospital letter as course is normally for 3 months.
|
|||||
diclofenac potassium | NON-FORMULARY | ||||
diclofenac sodium | |||||
Solution for injection | |||||
Akis (Flynn Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Voltarol (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
etoricoxib | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
febuxostat | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA164 |
|||
indometacin | NON-FORMULARY | ||||
ketoprofen | NON-FORMULARY | ||||
naproxen | FORMULARY PRODUCT | ||||
Gastro-resistant tablet | |||||
Naproxen (Non-proprietary) | NON-FORMULARY | ||||
Naprosyn EC (Atnahs Pharma UK Ltd) | NON-FORMULARY | ||||
Oral suspension | |||||
Naproxen (Non-proprietary) | NON-FORMULARY | ||||
sulindac | NON-FORMULARY | ||||
Musculoskeletal system / Arthritis | |||||
abatacept | HOSPITAL ONLY PRESCRIBING |
NICE TA195 NICE TA375 NICE TA715 |
|||
Solution for injection | |||||
Orencia (Bristol-Myers Squibb Pharmaceuticals Ltd, Imported (Germany)) | HOSPITAL ONLY PRESCRIBING | ||||
Orencia ClickJect (Bristol-Myers Squibb Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
aceclofenac | NON-FORMULARY | ||||
adalimumab | HOSPITAL ONLY PRESCRIBING |
NICE TA187 NICE TA329 NICE TA199 NICE TA195 NICE TA375 NICE TA715 NICE TA383 NICE TA392 NICE TA146 NICE TA460 |
|||
Solution for injection | |||||
Humira (AbbVie Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
anakinra | HOSPITAL ONLY PRESCRIBING |
NICE TA685 |
|||
Solution for injection | |||||
Kineret (Swedish Orphan Biovitrum Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
apremilast | HOSPITAL ONLY PRESCRIBING |
NICE TA433 NICE TA419 |
|||
azathioprine | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
AZATHIOPRINE - HOSPITAL ONLY INDICATIONS
Azathioprine is HOSPITAL ONLY for SEVERE ATOPIC DERMATITIS and RENAL TRANSPLANTATION |
|||||
baricitinib | HOSPITAL ONLY PRESCRIBING |
NICE TA466 NICE TA681 NICE TA926 |
|||
capsaicin | NON-FORMULARY | ||||
NHS England Rubefacents
NHS England Guidance (Dec-17):
Resource: Patient leaflet explaining NHS Changes to rubefacents prescribing |
|||||
celecoxib | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
certolizumab pegol | HOSPITAL ONLY PRESCRIBING |
NICE TA375 NICE TA383 NICE TA415 NICE TA445 NICE TA574 |
|||
Solution for injection | |||||
Cimzia (UCB Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
chloroquine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Oral solution | |||||
Malarivon (Wallace Manufacturing Chemists Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
ciclosporin | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA369 |
|||
CICLOSPORIN (NEORAL)
Ciclosporin (Neoral) is HOSPITAL ONLY for renal transplant patients and severe resistant childhood psoriasis and atopic eczema |
|||||
Oral solution | |||||
Neoral (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for infusion | |||||
Sandimmun (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
cyclophosphamide | |||||
Powder for solution for injection | |||||
Cyclophosphamide (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
diclofenac potassium | NON-FORMULARY | ||||
diclofenac sodium | FORMULARY PRODUCT | ||||
Modified-release tablet | |||||
Dicloflex 75mg SR (Dexcel-Pharma Ltd) | NON-FORMULARY | ||||
Dicloflex Retard (Dexcel-Pharma Ltd) | NON-FORMULARY | ||||
Enstar XL (Ennogen Pharma Ltd) | NON-FORMULARY | ||||
Solution for injection | |||||
Akis (Flynn Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Voltarol (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
etanercept | HOSPITAL ONLY PRESCRIBING |
NICE TA103 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA383 |
|||
Solution for injection | |||||
Benepali (Biogen Idec Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Enbrel (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Enbrel MyClic (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Erelzi (Sandoz Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Enbrel (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
etodolac | NON-FORMULARY | ||||
Modified-release tablet | |||||
Etolyn (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Etopan XL (Sun Pharmaceutical Industries Europe B.V.) | NON-FORMULARY | ||||
Lodine SR (Almirall Ltd) | NON-FORMULARY | ||||
etoricoxib | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
flurbiprofen | NON-FORMULARY | ||||
glucosamine | NON-FORMULARY | ||||
golimumab | HOSPITAL ONLY PRESCRIBING |
NICE TA220 NICE TA375 NICE TA225 NICE TA383 NICE TA497 NICE TA329 |
|||
Solution for injection | |||||
Simponi (Merck Sharp & Dohme (UK) Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
guselkumab | HOSPITAL ONLY PRESCRIBING |
NICE TA521 NICE TA815 |
|||
hydroxychloroquine sulfate | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
ibuprofen | FORMULARY PRODUCT | ||||
Orodispersible tablet | |||||
Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) | NON-FORMULARY | ||||
Modified-release tablet | |||||
Brufen Retard (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Modified-release capsule | |||||
Ibuprofen (Non-proprietary) | NON-FORMULARY | ||||
Effervescent granules | |||||
Brufen (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Oral suspension | |||||
Ibuprofen (Non-proprietary) | FORMULARY PRODUCT | ||||
Brufen (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | NON-FORMULARY | ||||
indometacin | NON-FORMULARY | ||||
infliximab | HOSPITAL ONLY PRESCRIBING |
NICE TA134 NICE TA195 NICE TA375 NICE TA715 NICE TA199 NICE TA187 NICE TA163 NICE TA329 NICE TA383 |
|||
ketoprofen | NON-FORMULARY | ||||
Modified-release capsule | |||||
Oruvail (Sanofi) | NON-FORMULARY | ||||
leflunomide | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
mefenamic acid | FORMULARY PRODUCT | ||||
Oral suspension | |||||
Mefenamic acid (Non-proprietary) | FORMULARY PRODUCT | ||||
meloxicam | FORMULARY PRODUCT | ||||
methotrexate | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
METHOTREXATE FOR ARTHRITIS IN CHILDREN
Methotrexate is HOSPITAL ONLY for arthritis in children. Injection formulations are HOSPITAL ONLY. |
|||||
Shared Care Guideline
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
|
|||||
Shared Care Guideline
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. Click here for the Shared Care Guideline Repository If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
|
|||||
Oral solution | |||||
Methotrexate (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for injection | |||||
Methotrexate (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Methofill (Accord-UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Metoject PEN (medac UK) | HOSPITAL ONLY PRESCRIBING | ||||
Nordimet (Nordic Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Zlatal (Nordic Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Methotrexate (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
nabumetone | NON-FORMULARY | ||||
naproxen | FORMULARY PRODUCT | ||||
Gastro-resistant tablet | |||||
Naproxen (Non-proprietary) | NON-FORMULARY | ||||
Naprosyn EC (Atnahs Pharma UK Ltd) | NON-FORMULARY | ||||
Oral suspension | |||||
Naproxen (Non-proprietary) | NON-FORMULARY | ||||
penicillamine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
piroxicam | NON-FORMULARY | ||||
Orodispersible tablet | |||||
Feldene Melt (Pfizer Ltd) | NON-FORMULARY | ||||
rituximab | HOSPITAL ONLY PRESCRIBING |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
Solution for injection | |||||
MabThera (Roche Products Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
MabThera (Roche Products Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Rixathon (Sandoz Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Truxima (Celltrion Healthcare UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
sulfasalazine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Gastro-resistant tablet | |||||
Sulfasalazine (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Salazopyrin EN (Pfizer Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Oral suspension | |||||
Sulfasalazine (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Suppository | |||||
Salazopyrin (Pfizer Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
sulindac | NON-FORMULARY | ||||
tenoxicam | NON-FORMULARY | ||||
tiaprofenic acid | NON-FORMULARY | ||||
tocilizumab | HOSPITAL ONLY PRESCRIBING |
NICE TA375 NICE TA247 NICE TA518 NICE TA878 |
|||
Solution for injection | |||||
RoActemra (Roche Products Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
RoActemra (Roche Products Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
tofacitinib | HOSPITAL ONLY PRESCRIBING |
NICE TA480 NICE TA543 NICE TA920 NICE TA547 |
|||
upadacitinib | HOSPITAL ONLY PRESCRIBING |
NICE TA665 NICE TA744 NICE TA768 NICE TA829 NICE TA861 NICE TA814 NICE TA856 NICE TA905 |
|||
Upadacitinib for Crohn's Disease
Last line targeted therapy for patients who experienced treatment failure and/or when other targeted therapies currently approved by NICE are not suitable |
|||||
Upadacitinib for Active ankylosing spondylitis (TA829)
Active ankylosing spondylitis that is not controlled well enough with conventional therapy in adults, only if tumour necrosis factor (TNF)-alpha inhibitors are not suitable or do not control the condition well enough. |
|||||
ustekinumab | HOSPITAL ONLY PRESCRIBING |
NICE TA180 NICE TA340 NICE TA456 NICE TA633 |
|||
Solution for injection | |||||
Stelara (Janssen-Cilag Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Stelara (Janssen-Cilag Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Musculoskeletal system / Neuromuscular disorders | |||||
riluzole | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA20 |
|||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
Oral suspension | |||||
Teglutik (Martindale Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Musculoskeletal system / Myasthenia gravis and Lambert-Eaton myasthenic syndrome | |||||
amifampridine | HOSPITAL ONLY PRESCRIBING | ||||
neostigmine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
NEOSTIGMINE
PARENTERAL FORMULATION IS FOR HOSPITAL PRESCRIBING ONLY |
|||||
pyridostigmine bromide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Musculoskeletal system / Nocturnal leg cramps | |||||
quinine | FORMULARY PRODUCT | ||||
Musculoskeletal system / Myotonic disorders | |||||
mexiletine | HOSPITAL ONLY PRESCRIBING |
NICE TA748 |
|||
Musculoskeletal system / Spasticity | |||||
baclofen | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
BACLOFEN
PARENTERAL FORMULATION IS FOR HOSPITAL PRESCRIBING ONLY |
|||||
Oral solution | |||||
Baclofen (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Lioresal (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Lyflex (Rosemont Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Solution for injection | |||||
Baclofen (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Lioresal (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Baclofen (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Lioresal (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
cannabis extract | HOSPITAL ONLY PRESCRIBING | ||||
Spray | |||||
Sativex (GW Pharma Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
SHARED CARE GUIDELINES - National Hospital of Neurology and Neurosurgery
Please note, Sativex recommended by specialist from National Hospital of Neurology and Neuroscience for Multiple Sclerosis related Spasticity, can be prescribed in primary care under shared care agreement. The shared care guideline can be accessed by Click here. |
|||||
dantrolene sodium | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Powder for solution for injection | |||||
Dantrium (Forum Health Products Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
diazepam | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Oral suspension | |||||
Diazepam (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Oral solution | |||||
Diazepam (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Solution for injection | |||||
Diazepam (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
methocarbamol | NON-FORMULARY | ||||
tizanidine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |